Note 2 - Segment Information

12 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 2. Segment Information

We design, develop, manufacture, and market products for endoscopy in two reportable segments: medical and industrial.

Management evaluates the revenue and profitability performance of each of our segments to make operating and strategic decisions. We have no intersegment revenue.

Fiscal Year Ended March 31,	Medical			Industrial			Adjustments*			Consolidated
2014
Net sales	$	14,133		$	2,975		$	-		$	17,108
Gross profit		3,469			1,029			-			4,498
Operating loss		(7,435	)		(9	)		-			(7,444	)
Depreciation and amortization		684			11			-			695
Assets		11,243			1,775			(2,185	)		10,833
Expenditures for fixed assets		53			-			-			53
2013
Net sales	$	11,630		$	3,657		$	-		$	15,287
Gross profit		3,102			1,240			-			4,342
Operating loss		(8,381	)		(96	)		-			(8,477	)
Depreciation and amortization		772			23			-			795
Assets		11,833			1,466			(1,922	)		11,377
Expenditures for fixed assets		95			-			-			95

	March 31,
*Adjustments	2014			2013
Intercompany eliminations	$	(1,499	)	$	(1,236	)
Investment in subsidiaries		(686	)		(686	)
Total adjustments	$	(2,185	)	$	(1,922	)

The following table presents the reconciliation of loss before provision for income taxes:

	Fiscal Year Ended March 31,
	2014			2013
Operating loss	$	(7,444	)	$	(8,477	)
Interest expense, net		(191	)		(499	)
Debt cost expense		(43	)		(272	)
Loss on extinguishment of debt		-			(1,244	)
Other, net		(24	)		(53	)
Loss before provision for income taxes	$	(7,702	)	$	(10,545	)

The following table presents net sales based on the geographic location of the external customer. The United Kingdom accounted for 14% of our worldwide net sales in fiscal 2014. No individual foreign country accounted for more than 10% of our worldwide net sales in fiscal 2013.

	Fiscal Year Ended March 31,
	2014				2013
United States	$	11,435	67	%	$	10,296	67	%
Europe		4,642	27	%		3,527	23	%
Asia and Australia		349	2	%		345	2	%
Canada		274	2	%		471	3	%
Middle East and Africa		254	1	%		468	3	%
Central and South America		154	1	%		180	2	%
Net sales	$	17,108	100	%	$	15,287	100	%